766 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
Should Investors Buy AbbVie Right Now for Its Dividend? https://www.fool.com/investing/2019/10/16/should-investors-buy-abbvie-right-now-for-its-divi.aspx?source=iedfolrf0000001 Oct 16, 2019 - Amid concerns about its $63 billion Allergan buyout, is now a good time to invest in the pharmaceutical giant?
J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810 Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
3 Top Healthcare Dividend Stocks That Are Great Picks for Retirees https://www.fool.com/investing/2019/10/13/3-top-healthcare-dividend-stocks-that-are-great-pi.aspx?source=iedfolrf0000001 Oct 13, 2019 - High dividend yields. Solid long-term prospects. These stocks have exactly what retired investors are looking for.
J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector http://www.zacks.com/stock/news/557845/jj-jnj-to-start-q3-earnings-season-for-pharma-sector?cid=CS-ZC-FT-analyst_blog|earnings_preview-557845 Oct 10, 2019 - J&J's (JNJ) cancer drugs are expected to contribute significantly to third-quarter 2019 earnings. Generic/biosimilar headwinds are expected to hurt Pharma unit's sales.
Top Ranked Income Stocks to Buy for October 10th http://www.zacks.com/commentary/557481/top-ranked-income-stocks-to-buy-for-october-10th?cid=CS-ZC-FT-zacks_#1_rank_additions-557481 Oct 10, 2019 - Top Ranked Income Stocks to Buy for October 10th
3 Big Pharma Companies Driving Price Inflation https://www.fool.com/investing/2019/10/10/3-big-pharma-stocks-driving-price-inflation.aspx?source=iedfolrf0000001 Oct 10, 2019 - Could these biopharmaceutical giants continue growing if they stopped hiking up drug prices?
Gilead (GILD) Files NDA for RA Candidate Filgotinib in Japan http://www.zacks.com/stock/news/556224/gilead-gild-files-nda-for-ra-candidate-filgotinib-in-japan?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-556224 Oct 09, 2019 - Gilead's (GILD) new drug application for its JAK1 inhibitor filgotinib seeks treatment of rheumatoid arthritis in adult patients across Japan.
3 Top Dividend Stocks to Buy Right Now https://www.fool.com/investing/2019/10/06/3-top-dividend-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 Oct 06, 2019 - With high yields and solid growth prospects, these companies deserve income investors' attention.
5 Excellent GARP Picks Based on Discounted PEG http://www.zacks.com/stock/news/549226/5-excellent-garp-picks-based-on-discounted-peg?cid=CS-ZC-FT-analyst_blog|rw-549226 Oct 04, 2019 - While P/E gives an idea of stocks trading at a discount, PEG helps to find stocks with solid future potential.
The Zacks Analyst Blog Highlights: Cintas, Air Products, Walmart, Target and AbbVie http://www.zacks.com/stock/news/548892/the-zacks-analyst-blog-highlights-cintas-air-products-walmart-target-and-abbvie?cid=CS-ZC-FT-press_releases-548892 Oct 04, 2019 - The Zacks Analyst Blog Highlights: Cintas, Air Products, Walmart, Target and AbbVie

Pages: 123456789...77

<<<Page 4>